x
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
For
the quarterly period ended June 30,
2006.
|
o
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
For
the transition period from _________________to
______________.
|
Delaware
|
|
20-3101079
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
|
|
|
Large
Accelerated Filer o
|
Accelerated
Filer o
|
Non-Accelerated
Filer ý
|
Part
I.
|
Financial
Information
|
|
|
|
Item
1. Financial Statements (unaudited)
|
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
|
Item
3. Quantitative and Qualitative Disclosures About Market
Risk
|
|
|
|
|
Item
4. Controls and Procedures
|
|
|
Part
II.
|
Other
Information
|
|
|
|
Item
1. Legal Proceedings
|
|
|
|
Item
1A. Risk Factors
|
|
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
|
|
|
Item
3. Defaults Upon Senior Securities
|
|
|
|
Item
4. Submission of Matters to a Vote of Security Holders
|
|
|
|
Item
5. Other Information
|
|
|
|
Item
6. Exhibits
|
SIGNATURES
|
|
|
|
June
30, 2006
(unaudited)
|
December
31, 2005
|
|||||
ASSETS
|
|
|
|||||
Current
assets:
|
|
|
|||||
Cash
|
$
|
474,748
|
$
|
9,608
|
|||
Cash
and cash equivalents, held in trust
|
29,291,422
|
-
|
|||||
Prepaid
expenses
|
51,334
|
-
|
|||||
Other
assets, deferred offering costs
|
-
|
294,745
|
|||||
Total
current assets
|
29,817,504
|
304,353
|
|||||
Property
and equipment, net of accumulated depreciation of $532
|
5,988
|
-
|
|||||
Total
assets
|
$
|
29,823,492
|
$
|
304,353
|
|||
|
|||||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
|
|||||||
Current
liabilities:
|
|||||||
Accrued
expenses
|
$
|
118,348
|
$
|
132,096
|
|||
Notes
payable - stockholders
|
-
|
155,000
|
|||||
Deferred
underwriting costs
|
1,404,379
|
-
|
|||||
Total
liabilities
|
1,522,727
|
287,096
|
|||||
|
|||||||
Common
stock, subject to possible redemption - 764,627 shares at $7.14 per
share
and associated deferred interest of $113,954
|
5,573,389
|
-
|
|||||
|
|||||||
Stockholders’
Equity:
|
|||||||
Preferred
stock — $.0001 par value; 1,000,000 shares authorized; 0 shares issued and
outstanding
|
-
|
-
|
|||||
Common
stock—$.0001 par value; 89,000,000 shares authorized; issued and
outstanding: 4,781,307 at June 30, 2006 (including 764,627 shares
of
common stock subject to possible redemption) and 937,500 at December
31,
2005
|
478
|
94
|
|||||
Additional
paid-in capital
|
22,765,623
|
24,906
|
|||||
Deficit
accumulated during the development stage
|
(38,725
|
)
|
(7,743
|
)
|
|||
Total
stockholders’ equity
|
22,727,376
|
17,257
|
|||||
|
|||||||
Total
liabilities and stockholders’ equity
|
$
|
29,823,492
|
$
|
304,353
|
|
Three
months ended June 30,
2006
|
Inception
through June 30, 2005
|
Six
months
ended
June
30, 2006
|
Inception
through
June
30, 2006
|
|||||||||
Operating
expenses
|
$
|
257,743
|
$
|
88
|
$
|
579,449
|
$
|
584,481
|
|||||
Other
income and expense
|
|||||||||||||
Bank
interest income
|
5,650
|
-
|
6,236
|
6,236
|
|||||||||
Interest
on cash and cash equivalents held in trust
|
353,155
|
-
|
570,059
|
570,059
|
|||||||||
Interest
expense
|
(27,362
|
)
|
-
|
(27,828
|
)
|
(30,539
|
)
|
||||||
Total
other income and expense
|
331,443
|
-
|
548,467
|
545,756
|
|||||||||
|
|||||||||||||
Income/(Loss)
before provision for income taxes
|
73,700
|
(88
|
)
|
(30,982
|
)
|
(38,725
|
)
|
||||||
Provision
for income taxes
|
-
|
-
|
-
|
-
|
|||||||||
|
|||||||||||||
Net
income/(loss)
|
73,700
|
(88
|
)
|
(30,982
|
)
|
(38,725
|
)
|
||||||
|
|||||||||||||
Deferred
interest, attributable to common stock subject to possible
redemption
|
70,595
|
-
|
113,954
|
113,954
|
|||||||||
|
|||||||||||||
Net
income/(loss) allocable to holders of non-redeemable common
stock
|
$
|
3,105
|
$
|
(88
|
)
|
$
|
(144,936
|
)
|
$
|
(152,679
|
)
|
||
|
|||||||||||||
Net
income/(loss) per share - - basic and diluted
|
$
|
0.02
|
$
|
(0.00
|
)
|
$
|
(0.01
|
)
|
$
|
(0.02
|
)
|
Weighted
average number of shares outstanding - - basic and diluted
|
4,781,307
|
937,500
|
4,169,385
|
2,501,594
|
|||||||||
Net
income/(loss) per share exclusive of shares and related interest
subject
to possible redemption - - basic and diluted
|
$
|
0.00
|
$
|
(0.00
|
)
|
$
|
(0.04
|
)
|
$
|
(0.07
|
)
|
||
Weighted
average number of shares outstanding exclusive of shares subject
to
possible redemption - - basic and diluted
|
4,016,680
|
937,500
|
3,527,267
|
2,190,836
|
|
|
|
|
Deficit
|
|
|||||||||||
|
|
|
Paid-in
|
Accumulated
|
|
|||||||||||
|
|
|
Capital
|
During
the
|
Total
|
|||||||||||
|
Common
Stock
|
in
Excess
|
Development
|
Stockholders'
|
||||||||||||
|
Shares
|
Amount
|
of
Par
|
Stage
|
Equity
|
|||||||||||
|
|
|
|
|
|
|||||||||||
Stock
issuance on June 23, 2005 at $.027
|
937,500
|
$
|
94
|
$
|
24,906
|
$
|
25,000
|
|||||||||
Net loss | $ |
(7,743
|
) |
(
7,743
|
) | |||||||||||
Balances,
at December 31, 2005
|
937,500
|
$
|
94
|
$
|
24,906
|
$
|
(7,743
|
)
|
$
|
17,257
|
||||||
Stock
issuance on January 24, 2006 at $8
|
125,000
|
12
|
999,988
|
-
|
1,000,000
|
|||||||||||
Stock
issuance on January 30, 2006 at $8
|
3,625,000
|
362
|
28,999,638
|
-
|
29,000,000
|
|||||||||||
Stock
issuance on January 30, 2006 at $8
|
75,046
|
8
|
600,360
|
-
|
600,368
|
|||||||||||
Proceeds
from issuance of option to underwriters
|
-
|
-
|
100
|
-
|
100
|
|||||||||||
Expenses
of offerings
|
-
|
-
|
(2,417,117
|
)
|
-
|
(2,417,117
|
)
|
|||||||||
Less:
Proceeds subject to possible redemption of 764,627 shares and associated
deferred interest
|
-
|
-
|
(5,573,389
|
)
|
-
|
(5,573,389
|
)
|
|||||||||
Stock
based compensation
|
-
|
-
|
130,632
|
-
|
130,632
|
|||||||||||
Officer
and director option exercise
|
18,761
|
2
|
505
|
-
|
507
|
|||||||||||
Net
loss
|
-
|
-
|
-
|
(30,982
|
)
|
(30,982
|
)
|
|||||||||
Balances,
at June 30, 2006
|
4,781,307
|
$
|
478
|
$
|
22,765,623
|
$
|
(38,725
|
)
|
$
|
22,727,376
|
|
Six
months ended June 30, 2006
|
Inception
through June 30, 2005
|
Inception
through June 30, 2006
|
|||||||
Cash
flows from operating activities
|
|
|
||||||||
Net
loss
|
$
|
(30,982
|
)
|
$
|
(88
|
)
|
$
|
(38,725
|
)
|
|
Adjustment
to reconcile net loss to net cash provided
by operating activities:
|
||||||||||
Stock
based compensation
|
130,632
|
-
|
130,632
|
|||||||
Depreciation
expense
|
532
|
-
|
532
|
|||||||
Increase
in prepaid expenses
|
(51,334
|
)
|
-
|
(51,334
|
)
|
|||||
Increase
in accrued expenses
|
114,253
|
-
|
118,348
|
|||||||
Interest
earned on cash and cash equivalents, held in trust
|
(570,059
|
)
|
-
|
(570,059
|
)
|
|||||
Interest
expense on deferred underwriting costs
|
27,362
|
-
|
27,362
|
|||||||
Net
cash used in operating activities
|
(379,596
|
)
|
(88
|
)
|
(383,244
|
)
|
||||
|
||||||||||
Cash
flows from investing activities:
|
||||||||||
Purchases
of investments held in trust
|
(178,921,809
|
)
|
-
|
(178,921,809
|
)
|
|||||
Maturity
of investments held in trust
|
150,200,446
|
-
|
150,200,446
|
|||||||
Purchase
of property and equipment
|
(6,520
|
)
|
-
|
(6,520
|
)
|
|||||
Net
cash used in investing activities
|
(28,727,883
|
)
|
-
|
(28,727,883
|
)
|
|||||
|
||||||||||
Cash
flows from financing activities
|
||||||||||
Gross
proceeds from public offering and private placement
|
30,600,368
|
-
|
30,600,368
|
|||||||
Offering
costs
|
(873,356
|
)
|
(50,000
|
)
|
(1,040,100
|
)
|
||||
Proceeds
from issuance and exercises of options
|
607
|
-
|
607
|
|||||||
Repayment
of notes payable, stockholders
|
(155,000
|
)
|
-
|
(155,000
|
)
|
|||||
Proceeds
from notes payable, stockholders
|
-
|
125,000
|
155,000
|
|||||||
Proceeds
from sale of common stock to founding stockholders
|
-
|
25,000
|
25,000
|
|||||||
Net
cash provided by financing activities
|
29,572,619
|
100,000
|
29,585,875
|
|||||||
|
||||||||||
Net
increase in cash
|
465,140
|
99,912
|
474,748
|
|||||||
Cash,
beginning of period
|
9,608
|
-
|
-
|
|||||||
Cash,
end of period
|
$
|
474,748
|
$
|
99,912
|
$
|
474,748
|
||||
|
||||||||||
Supplemental
disclosure of cash flow information
|
||||||||||
Cash
paid for interest
|
$
|
3,177
|
$
|
-
|
$
|
3,177
|
||||
Supplemental
schedule of non-cash financing activities:
|
||||||||||
Accrual
of deferred underwriting costs
|
$
|
1,377,017
|
$
|
-
|
$
|
1,377,017
|
|
January
1, 2006
Through
June
30, 2006
|
|||
Current
tax expense
|
$
|
(16,806
|
)
|
|
Deferred
tax benefit
|
26,962
|
|||
Less:
Valuation allowance
|
(10,156
|
)
|
||
|
$
|
0
|
· |
to
exercise the warrants and pay the exercise price for such warrants at
a time when it may be disadvantageous for the holders to do
so,
|
· |
to
sell the warrants at the then current market price when they might
otherwise wish to hold the warrants, or
|
· |
to
accept the nominal redemption price which, at the time the warrants
are called for redemption, is likely to be substantially less than
the market value of the warrants.
|
|
|
|
Exhibit
No.
|
|
Description
|
10.1(1)
|
Lease
between the Company and Frost National Bank, Trustee For A Designated
Trust
|
|
31.1
|
|
Certification
of the Co-Chief Executive Officer (Principal Financial Officer) pursuant
to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
31.2
|
|
Certification
of the Co-Chief Executive Officer and (Principal Executive Officer)
pursuant to Rule 13a-14(a) of the Securities Exchange Act, as
amended
|
32.1
|
|
Certification
of the Co-Chief Executive Officers pursuant to 18 U.S.C. 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
.
|
99.1(2)
|
Consulting
Agreement with Alan Wachtel
|
|
99.2(2)
|
Consulting
Agreement with Mark Mellin
|
|
99.3(2)
|
Consulting
Agreement with Point Management
Associates
|
|
|
|
|
ARGYLE
SECURITY ACQUISITION CORPORATION
|
|
|
|
|
August
11, 2006
|
By:
|
/s/ Bob
Marbut
|
|
Bob
Marbut
|
|
|
Co-Chief
Executive Officer (Principal Accounting and Financial
officer)
|
|
|
|
|
|
|
|
By:
|
/s/ Ron
Chaimovski
|
|
Ron
Chaimovski
|
|
|
Co-Chief
Executive Officer (Principal Executive
Office)
|